Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15751279rdf:typepubmed:Citationlld:pubmed
pubmed-article:15751279lifeskim:mentionsumls-concept:C0206062lld:lifeskim
pubmed-article:15751279lifeskim:mentionsumls-concept:C0002570lld:lifeskim
pubmed-article:15751279lifeskim:mentionsumls-concept:C0007428lld:lifeskim
pubmed-article:15751279lifeskim:mentionsumls-concept:C0040018lld:lifeskim
pubmed-article:15751279lifeskim:mentionsumls-concept:C0205219lld:lifeskim
pubmed-article:15751279lifeskim:mentionsumls-concept:C0237881lld:lifeskim
pubmed-article:15751279lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:15751279pubmed:issue1-2lld:pubmed
pubmed-article:15751279pubmed:dateCreated2005-3-8lld:pubmed
pubmed-article:15751279pubmed:abstractTextTo determine the significance of proteases in interstitial lung diseases, we examined the activity of cathepsins, thrombin, and aminopeptidase in bronchoalveolar lavage (BAL) fluid from patients with these disorders. Significantly increased activities of cathepsin H and aminopeptidase were detected in BAL fluid from patients with idiopathic pulmonary fibrosis (IPF), cryptogenic organizing pneumonia (COP), chronic eosinophilic pneumonia (CEP) and hypersensitivity pneumonitis (HP). Significantly higher activity of cathepsin B was found in BAL fluid from patients with CEP. The activity of thrombin was significantly higher in patients with IPF and CEP. In patients with IPF, there were significant correlations between neutrophil number and the activity of cathepsin B, cathepsin H or aminopeptidase. In patients with COP and HP, the activity of the proteases was significantly higher in patients with higher number of lymphocytes than in those with lower number of lymphocytes. The present study suggests that the activity of the proteases is a useful marker in activity of the interstitial lung diseases, and may have a role in the pathogenesis of these disorders.lld:pubmed
pubmed-article:15751279pubmed:languageenglld:pubmed
pubmed-article:15751279pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15751279pubmed:citationSubsetIMlld:pubmed
pubmed-article:15751279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15751279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15751279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15751279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15751279pubmed:statusMEDLINElld:pubmed
pubmed-article:15751279pubmed:monthFeblld:pubmed
pubmed-article:15751279pubmed:issn1343-1420lld:pubmed
pubmed-article:15751279pubmed:authorpubmed-author:KimuraMakotoMlld:pubmed
pubmed-article:15751279pubmed:authorpubmed-author:SoneSaburoSlld:pubmed
pubmed-article:15751279pubmed:authorpubmed-author:TaniKenjiKlld:pubmed
pubmed-article:15751279pubmed:authorpubmed-author:SatoKeikoKlld:pubmed
pubmed-article:15751279pubmed:authorpubmed-author:MiyataJunyaJlld:pubmed
pubmed-article:15751279pubmed:authorpubmed-author:UrataTomoyuki...lld:pubmed
pubmed-article:15751279pubmed:authorpubmed-author:HayashiAkihit...lld:pubmed
pubmed-article:15751279pubmed:authorpubmed-author:OtsukaShinsak...lld:pubmed
pubmed-article:15751279pubmed:issnTypePrintlld:pubmed
pubmed-article:15751279pubmed:volume52lld:pubmed
pubmed-article:15751279pubmed:ownerNLMlld:pubmed
pubmed-article:15751279pubmed:authorsCompleteYlld:pubmed
pubmed-article:15751279pubmed:pagination93-100lld:pubmed
pubmed-article:15751279pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:meshHeadingpubmed-meshheading:15751279...lld:pubmed
pubmed-article:15751279pubmed:year2005lld:pubmed
pubmed-article:15751279pubmed:articleTitleThe significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.lld:pubmed
pubmed-article:15751279pubmed:affiliationDepartment of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.lld:pubmed
pubmed-article:15751279pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15751279pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15751279lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15751279lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15751279lld:pubmed